22 reviews

Botulax 200UI

Clostridium botulinum toxin type A · 200 units · lyophilised powder, single-dose vial. Manufactured by Hugel, Inc, South Korea.

200 UPer vial
Type AToxin serotype
2–8 °CStorage
HugelManufacturer
SKU: 03012
In Stock

Original price was: $95.90.Current price is: $85.90.
You save

Volume pricing
1 – 4 $95.90 base price
5 – 9 $94.46 1.5 % off
10 – 19 $93.50 2.5 % off
20+ $92.54 3.5 % off
  • Botulax 200UI delivers double the toxin content of the standard vial from Hugel, suiting larger or combined facial and body treatment sessions. It shares the same 99%+ purity and FDA-approved Letybo lineage as the 100UI version.
In Stock
Purchase & earn 4 Points!
Quantity Discount Price
1 - 4 — $85.90
5 - 9 — $94.46
10 - 19 — $93.50
20+ — $92.54
Add to Wishlist
Add to Wishlist

Professional use only. This product is intended for administration by licensed healthcare practitioners trained in the relevant anatomy and injection technique. By ordering you confirm you are authorised to purchase and handle products of this class in your jurisdiction. Availability and permitted use vary by country — please verify local regulations before ordering.

Important Information for U.S. Customers:

In accordance with applicable U.S. FDA regulations, this product is not available for purchase or shipment to U.S. addresses through this website. Customers in the United States should obtain botulinum toxin products through appropriately licensed and authorized U.S. distribution channels. A valid medical license or registration certificate is required to process any product-related claim.

Did you like this product? Add to favorites now and follow the product.

Add to Wishlist
Add to Wishlist
Have a Question? Ask a Specialist

(+82) 10 7364 7998 Send a message on WhatsApp.

Low Prices

Price match guarantee

Guaranteed Shipment.

Always the correct part

In-House Experts.

We know our products

Easy Returns.

Quick & Hassle Free

Product overview

The 200-unit Botulax vial, for higher-volume treatment sessions

Botulax 200UI is the mid-size vial in Hugel’s botulinum toxin type A range. The formulation is identical to the 100 U and 300 U presentations — the difference is how many units are in the vial, and therefore how many you open in a session.

This size suits practitioners combining facial treatment with larger muscle groups such as masseter or platysma, or running consecutive appointments where a 100 U vial would be exhausted early. Because reconstituted product is single-patient use, the right vial size is the one that matches a single session rather than a week of bookings.

The same underlying formulation is marketed in the United States as Letybo (letibotulinumtoxinA-wlbg), which received FDA approval on 29 February 2024 for the temporary improvement in the appearance of moderate to severe glabellar lines, following three Phase III trials — BLESS I, II and III — enrolling more than 1,000 subjects. That approval covers glabellar lines only, and a Korean-market Botulax carton is a separate registration from the US-labelled Letybo article.

Hugel purifies the active substance using Size Exclusion High Performance Liquid Chromatography (SE-HPLC), a step that separates the neurotoxin from residual process material and supports batch-to-batch consistency.

Fewer vials per session

Double the units of the 100 U presentation, for lists that combine facial work with larger muscle groups.

Shared with an FDA-approved product

The same formulation is approved in the US as Letybo for glabellar lines, supported by three Phase III trials.

SE-HPLC purification

Size exclusion chromatography separates the neurotoxin from residual process material, supporting batch consistency.

Practitioner-set dilution

Reconstitution volume is chosen by the injector, so concentration is matched to the treatment area.

Day 0 Treatment administered
Days 2–7 Onset commonly reported
2–4 weeks Effect assessed at review
3–4 months Typical review interval
Retreatment As clinically indicated
Key features

Why practitioners choose Botulax 200UI

Sized for higher-volume sessions

Treating masseter, platysma or several patients in sequence runs through a 100 U vial quickly. This size reduces how many you open.

A formulation with an FDA-approved counterpart

Letybo, approved in the United States in February 2024 for glabellar lines, is the same underlying formulation.

Chromatographic purification

Hugel uses SE-HPLC to separate the neurotoxin from residual process material, which supports consistent potency between batches.

Interchangeable within the range

100 U, 200 U and 300 U share one formulation, so you can change vial size without changing product or retraining.

Indications & Treatment Areas

Aesthetic & therapeutic applications

The indication under which this formulation holds US approval, as Letybo, is set out first. The remaining areas are commonly treated in practice, but approval status differs between markets — always work from the prescribing information registered in the country where you practise.

Glabellar lines (frown lines)

Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. This is the sole indication covered by the February 2024 US approval of Letybo.

Lateral canthal lines (crow's feet)

Lines at the outer eye produced by orbicularis oculi activity. Widely treated in aesthetic practice, though whether it is an approved indication for this product depends on your market — it is not covered by the US approval.

Lower face and jawline

Masseter and platysma treatment for muscle contouring, which is where a 200 U vial is most often used. Approval status varies widely by country and this is frequently a practitioner-led application rather than a labelled indication.

Therapeutic registrations

In some markets the manufacturer’s registration extends to conditions such as blepharospasm and post-stroke upper limb spasticity. These vary considerably by country — consult the prescribing information approved where you practise.

A note on scope

Botulinum toxin products are prescription-only medicines. Any use outside the indications approved in your jurisdiction is a clinical decision made by the treating practitioner under their own professional judgement and local regulatory framework. Korea Filler Experts supplies the product; nothing here should be read as a recommendation to treat any medical condition.

Composition

What is inside Botulax 200UI

Active substance Clostridium botulinum toxin type A
Strength 200 Units per vial
Strain Clostridium botulinum CBFC26
Stabiliser Human serum albumin
Tonicity agent Sodium chloride
Pharmaceutical form Lyophilised powder for solution for injection
Purification Size Exclusion High Performance Liquid Chromatography (SE-HPLC)
Diluent Preservative-free 0.9% sodium chloride injection (not supplied)
Container Single-use glass vial with rubber stopper and flip-off cap
Route Intramuscular injection
Manufacturer Hugel, Inc, South Korea
Regulatory class Prescription-only medicine (professional use)

Reading the carton

Before you accept a delivery, check four things:

  • The lot / batch number on the carton matches the number printed on the vial.
  • The expiry date leaves you enough working life — we do not dispatch stock with under 6 months remaining unless agreed in advance.
  • The flip-off cap is intact and the vial seal has not been disturbed.
  • The carton arrived cold, with the coolant pack still chilled.

Vial looks empty? The contents are freeze-dried under vacuum, so the powder forms a thin film that is hard to see against the glass. This is expected and is not a sign of a short fill.

What each component does

  • Botulinum toxin type A — the active substance. It temporarily reduces the release of acetylcholine at the neuromuscular junction, lowering activity in the injected muscle.
  • Human serum albumin — stabilises the toxin protein during freeze-drying, storage and reconstitution.
  • Sodium chloride — brings the reconstituted solution to a tonicity suitable for injection.
How to use

How to prepare and use Botulax 200UI

Reference information for licensed practitioners. Reconstitution and administration must follow the prescribing information approved in your market and your own clinical governance procedures.

Step by step

  1. Inspect the vial

    It should be colourless and transparent, with white or pale yellow powder visible. Check the lot number and expiry date, and confirm the flip-off cap is intact.

  2. Prepare the diluent

    Draw the required volume of preservative-free 0.9% sterile sodium chloride into a sterile syringe. Note that a 200 U vial needs twice the volume of a 100 U vial to reach the same concentration.

  3. Introduce the saline slowly

    Insert the needle at an angle and let the vacuum draw the saline in. Direct the stream against the vial wall rather than onto the powder.

  4. Mix gently

    Rotate the vial slowly to dissolve the cake. Do not shake vigorously — agitation can denature the protein.

  5. Confirm before drawing

    The solution should be clear, colourless and free of particles. Discard the vial if it is cloudy, discoloured or contains visible matter.

  6. Record and refrigerate

    Note the reconstitution date and time on the vial, store at 2–8 °C, and use within the period stated in your approved prescribing information.

Dilution reference

Diluent added Units per 0.1 mL Total volume
2.0 mL 10 U 2.0 mL
4.0 mL 5 U 4.0 mL
5.0 mL 4 U 5.0 mL
8.0 mL 2.5 U 8.0 mL
10.0 mL 2 U 10.0 mL

Administration notes

The diluent volumes above are double those for a 100 U vial, because the vial contains twice the units. Adding 2.5 mL to a 200 U vial gives 8 units per 0.1 mL, not 4 — a common slip when switching vial size mid-list.

Materials needed: preservative-free 0.9% sterile saline, a sterile syringe (typically 30G), gloves and alcohol swabs. None of these are supplied with the vial.

  • Units of botulinum toxin are product-specific. Do not convert or substitute units between brands.
  • Dose per site, total dose and injection technique must follow the prescribing information approved in your market.
  • Draw reconstituted product immediately before injection.
  • Treatment intervals should not be shortened below the minimum stated in the prescribing information.

After treatment

  • Avoid rubbing or massaging the treated area for at least 24 hours
  • Stay upright and avoid lying down for 4 to 6 hours
  • Avoid strenuous exercise for 24 to 48 hours
  • Avoid saunas, hot tubs and excessive sun exposure for at least 24 hours
  • Delay facials, microdermabrasion or chemical peels for at least a week
  • Mild redness, swelling or bruising can occur and usually settles within a few days
Storage & handling

Storing and handling Botulax 200UI

Unopened vial

Store refrigerated at 2–8 °C in the original carton, protected from light. Do not freeze. Always work to the expiry date printed on the carton.

After reconstitution

Keep at 2–8 °C and use within the period stated in your approved prescribing information. Do not freeze reconstituted solution. Single-patient use only — a 200 U vial is not pooled across patients.

Cold chain on arrival

Transfer stock into a monitored medical refrigerator on arrival and keep a temperature log. If a shipment arrives warm, photograph the packaging and contact us before putting it into clinical service.

Handling and shipping note

Do not use the vial if the powder is discoloured, if the reconstituted solution is cloudy or contains particles, if the expiry date has passed, or if the cold chain is known to have been broken. Dispose of unused product and used vials as clinical waste in line with local requirements.

In the box

What's included with Botulax 200UI

1 × Botulax 200 U vial Lyophilised powder, sealed
Original Hugel carton With lot number and expiry date
Manufacturer package insert Korean-market labelling
Insulated cold-chain packaging Coolant packs and liner
Batch and expiry confirmation Available before dispatch on request
Tracked shipping Tracking number issued on dispatch

Diluent (0.9% sodium chloride injection), syringes and needles are not supplied with this product and must be sourced separately.

FAQ

Botulax 200UI — frequently asked questions

What is Botulax 200UI?

Botulax 200UI is a botulinum toxin type A product manufactured by Hugel, Inc. in South Korea. It is supplied as a sterile freeze-dried powder in a single 200-unit vial and reconstituted with preservative-free 0.9% sodium chloride before injection by a licensed practitioner.

How does it differ from the 100 U vial?

Only in how many units are in the vial. The formulation, strain and excipients are identical. The practical difference is dilution: to reach 4 units per 0.1 mL you add 5.0 mL to a 200 U vial where you would add 2.5 mL to a 100 U vial.

Is Botulax the same as Letybo?

They share the same underlying formulation. Letybo (letibotulinumtoxinA-wlbg) is the brand Hugel markets in the United States, where it received FDA approval on 29 February 2024 for the temporary improvement in the appearance of moderate to severe glabellar lines.

They are separate registrations. A Korean-market Botulax carton is not the FDA-approved, US-labelled Letybo article, and the US approval covers glabellar lines only.

Which vial size should I order?

Size the vial to a single session rather than to a week of bookings, because reconstituted product is single-patient use. The 100 U vial suits face-focused lists; 200 U and 300 U reduce how many you open when treating larger muscle groups such as masseter or platysma, or running consecutive appointments.

Why does the vial look empty?

The contents are freeze-dried under vacuum, so the active substance forms a very thin, almost transparent film on the base or wall of the vial. This is normal for lyophilised toxins and is not a sign of a short fill. The powder becomes obvious once saline is introduced.

Can I substitute Botulax units for another brand's units?

No. Units of botulinum toxin are specific to each product and are not interchangeable between brands. Dosing must be taken from the prescribing information for the product in your hand.

What shelf life will my stock have?

We do not dispatch stock with less than six months of remaining shelf life unless you have specifically agreed to it. If you need a particular expiry window, tell us before you order and we will allocate accordingly.

What happens if my shipment arrives warm?

Do not use it. Photograph the outer box, the insulated liner, the coolant packs and the vial carton, and contact us the same day with your order number. We will review the cold-chain evidence and arrange a replacement where the failure occurred in transit.

Who is allowed to buy this product?

Botulinum toxin is a prescription-only medicine. Purchase and use are restricted to licensed healthcare professionals qualified to prescribe or administer injectable prescription medicines in their jurisdiction, with appropriate training in the relevant anatomy and injection technique. We do not sell to consumers.